Articles tagged "COVID-19"

2022 American Transplant Congress
Impact of ATG Dose Reduction on Kidney Transplant Outcomes During the Covid-19 Pandemic
P. A. Than¹, F. De Leon¹, K. Jen², N. Goussous¹, R. V. Perez¹, A. X. Wang³
¹Transplant Surgery, UC Davis, Sacramento, CA, ²Pathology, UC Davis, Sacramento, CA, ³Transplant Nephrology, UC Davis, Sacramento, CA
*Purpose: During the COVID-19 pandemic, many transplant centers modified induction immunosuppression regimens. Beginning December 2020, our center reduced anti-thymocyte globulin (ATG) protocol dosing by up…
2022 American Transplant Congress
Effect of Covid-19 Diagnosis on Organ Donation and Transplantation
L. Baetje¹, A. Cheng¹, S. Sander², L. Markham², M. Ott², J. Finn², A. Wee³, K. Dyer⁴, A. Atluri¹, D. Jahandar¹, M. Moncure⁴
¹University of Missouri - Kansas City School of Medicine, Kansas City, MO, ²Midwest Transplant Network, Westwood, KS, ³Transplantation Center, Cleveland Clinic, Cleveland, OH, ⁴University Health Kansas City, Kansas City, MO
*Purpose: The coronavirus disease 2019 (COVID-19) pandemic has challenged many aspects of healthcare, including organ donation and transplantation. The purpose of this study is to…
2022 American Transplant Congress
Impact of COVID on Transplant Professionalism
A. Luxon¹, D. Brennan², F. Latif³, M. Flattery⁴, S. Aryal⁵
¹CareDx, South San Francisco, CA, ²Johns Hopkins Medical Institute, Baltimore, MD, ³Columbia University, New York, NY, ⁴Virginia Commonwealth University, Richmond, VA, ⁵Inova Fairfax Hospital, Falls Church, VA
*Purpose: Although, much has been written about COVID risk and immunization efficacy in transplant recipients, there is little data on the impact of COVID on…
2022 American Transplant Congress
The Impact of Maintenance Immunosuppressive Regimen on COVID-19 Outcomes Among Kidney Transplant Patients
T. V. Sandes-Freitas¹, L. Modelli de Andrade², L. Requião-Moura³, J. Medina-Pestana³, H. Tedesco-Silva³, A. on behalf of Covid-19 KT Brazil Study Group¹
¹Universidade Federal do Ceará / Unidade Pesquisa Clínica CH-UFC/EBSERH, Fortaleza, Brazil, ²Universidade Estadual Paulista - UNESP, Botucatu, Brazil, ³Universidade Federal de São Paulo / Hospital do Rim, São Paulo, Brazil
*Purpose: Compared to azathioprine (AZA), mycophenolate (MPA) is implicated in an increased risk of several viral infections. Contrariwise, mTOR inhibitors (mTORi) are protective. Therefore, the…
2022 American Transplant Congress
Outcomes of Kidney Transplant Recipients with Covid-19 in Singapore Treated with Sotrovimab in the Era of the Delta Variant
M. R. D'Costa¹, H. K. Sran¹, E. Wong¹, Z. Chang², Y. Chua², J. Somani³, L. Lum³, A. Vathsala¹
¹National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore, ²Medicine, National University Hospital, Singapore, Singapore, ³Infectious Diseases, National University Hospital, Singapore, Singapore
*Purpose: Kidney transplant recipients (KTRs) are at higher risk for severe COVID-19 caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Sotrovimab decreases the risk…
2022 American Transplant Congress
Prevalence and Characteristics of Covid-19-Associated Pulmonary Diagnoses in Lung Transplant Patients in the United States
T. G. Mupfudze¹, A. R. Wilk¹, R. R. Goff¹, M. Valapour², J. Miller³, M. Budev², E. D. Lease⁴
¹Research Department, United Network for Organ Sharing, Richmond, VA, ²Respiratory Institute, Cleveland Clinic, Cleveland, OH, ³Scientific Registry of Transplant Recipients, Minneapolis, MN, ⁴Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA
*Purpose: Lung transplant may be a viable treatment option for select patients with non-recoverable COVID-19-associated acute respiratory distress syndrome (ARDS) and COVID-19-associated pulmonary fibrosis. This…
2022 American Transplant Congress
Effect Of A Fourth Covid-19 Vaccine Dose On Omicron Variant Neutralization In Solid Organ Transplant Recipients
A. Karaba, A. Abedon, J. Alejo, C. X. Qin, D. Warren, J. Ruff, T. Aytenfisu, T. S. Johnston, O. Akinde, A. Pekosz, S. Klein, A. Cox, D. Segev, A. Tobian, W. Werbel
Johns Hopkins University, Baltimore, MD
*Purpose: Humoral response to COVID-19 vaccines is attenuated in many solid organ transplant recipients (SOTRs), necessitating additional primary and booster vaccinations. The omicron variant demonstrates…
2022 American Transplant Congress
Exacerbation of Racial Disparities in Living Donor Kidney Transplant During the Covid-19 Pandemic
N. Singh¹, R. Li², T. Alhamad³, M. A. Schnitzler⁴, R. B. Mannon⁵, M. D. Doshi⁶, K. J. Woodside⁶, B. E. Hippen⁷, M. Cooper⁸, J. Snyder⁹, D. A. Axelrod¹⁰, K. L. Lentine⁴
¹Willis Knighton Health System, Shreveport, LA, ²Saint Louis University, Saint Louis, MO, ³Washington University, Saint Louis, MO, ⁴Saint Louis University Center for Abdominal Transplantation, Saint Louis, MO, ⁵University of Nebraska Medical Center, Omaha, NE, ⁶University of Michigan, Ann Arbor, MI, ⁷Metrolina Nephrology, Associates, Charlotte, NC, ⁸Medstar Georgetown Transplant Institute, Washington, DC, ⁹Hennepin Healthcare Research Institute, Minneapolis, MN, ¹⁰University of Iowa, Iowa City, IA
*Purpose:The SARS-CoV-2 or coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted racial and ethnic minority groups in the United States. Although, kidney transplant procedures decreased…
2022 American Transplant Congress
Improved Mortality in COVID-19 Kidney Transplant Recipients Treated with Bamlanivimab
A. Hamiduzzaman, U. Reddy
Nephrology, UC Irvine, Orange, CA
*Purpose: Transplant recipients are particularly vulnerable to catastrophic sequelae of COVID-19. In an early multi-center study of 482 solid organ transplant (SOT) recipients with COVID-19,…
2022 American Transplant Congress
The High Incidence of Long-COVID-19 in Kidney Transplant Recipients: A Longitudinal Cohort Study
V. Lafico Teixeira Gomes, P. Quintino, H. Tedesco, J. Medina, C. Eduardo Neves Amorim, M. Cristelli
Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil
*Purpose: This study aimed to investigate the clinical consequences at 3 months after symptom onset among kidney transplant recipients surviving COVID-19.*Methods: This is an ongoing…